Milestone Pharmaceuticals Stock Probability of Future Stock Price Finishing Under 0.01
| MIST Stock | USD 1.99 0.12 6.42% |
Milestone |
Milestone Pharmaceuticals Target Price Odds to finish below 0.01
The tendency of Milestone Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 0.01 or more in 90 days |
| 1.99 | 90 days | 0.01 | near 1 |
Based on a normal probability distribution, the odds of Milestone Pharmaceuticals to drop to $ 0.01 or more in 90 days from now is near 1 (This Milestone Pharmaceuticals probability density function shows the probability of Milestone Stock to fall within a particular range of prices over 90 days) . Probability of Milestone Pharmaceuticals price to stay between $ 0.01 and its current price of $1.99 at the end of the 90-day period is close to 99 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.56 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Milestone Pharmaceuticals will likely underperform. Additionally Milestone Pharmaceuticals has an alpha of 0.3142, implying that it can generate a 0.31 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Milestone Pharmaceuticals Price Density |
| Price |
Predictive Modules for Milestone Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Milestone Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Milestone Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Milestone Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Milestone Pharmaceuticals is not an exception. The market had few large corrections towards the Milestone Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Milestone Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Milestone Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.31 | |
β | Beta against Dow Jones | 1.56 | |
σ | Overall volatility | 0.17 | |
Ir | Information ratio | 0.13 |
Milestone Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Milestone Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Milestone Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Milestone Pharmaceuticals may become a speculative penny stock | |
| Milestone Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 1000 K. Net Loss for the year was (59.69 M) with profit before overhead, payroll, taxes, and interest of 5 M. | |
| Milestone Pharmaceuticals currently holds about 86.24 M in cash with (46.42 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.87, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Milestone Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Roughly 57.0% of the company shares are owned by institutional investors | |
| Latest headline from gurufocus.com: Milestone Pharmaceuticals to Present at the Piper Sandler 36th Annual Healthcare Conference |
Milestone Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Milestone Stock often depends not only on the future outlook of the current and potential Milestone Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Milestone Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 43 M | |
| Cash And Short Term Investments | 66 M |
Milestone Pharmaceuticals Technical Analysis
Milestone Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Milestone Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Milestone Pharmaceuticals. In general, you should focus on analyzing Milestone Stock price patterns and their correlations with different microeconomic environments and drivers.
Milestone Pharmaceuticals Predictive Forecast Models
Milestone Pharmaceuticals' time-series forecasting models is one of many Milestone Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Milestone Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Milestone Pharmaceuticals
Checking the ongoing alerts about Milestone Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Milestone Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Milestone Pharmaceuticals may become a speculative penny stock | |
| Milestone Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 1000 K. Net Loss for the year was (59.69 M) with profit before overhead, payroll, taxes, and interest of 5 M. | |
| Milestone Pharmaceuticals currently holds about 86.24 M in cash with (46.42 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.87, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Milestone Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Roughly 57.0% of the company shares are owned by institutional investors | |
| Latest headline from gurufocus.com: Milestone Pharmaceuticals to Present at the Piper Sandler 36th Annual Healthcare Conference |
Additional Tools for Milestone Stock Analysis
When running Milestone Pharmaceuticals' price analysis, check to measure Milestone Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Milestone Pharmaceuticals is operating at the current time. Most of Milestone Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Milestone Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Milestone Pharmaceuticals' price. Additionally, you may evaluate how the addition of Milestone Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.